Highlights

  • CDSCO approves anti-diabetes drug
  • Dapagliflozin will detect early heart failures
  • AstraZeneca calls it big boost for medical fraternity

Latest news

Sidharth Malhotra-Kiara Advani wedding: First pics are out; couple seeks blessings

Sidharth Malhotra-Kiara Advani wedding: First pics are out; couple seeks blessings

OnePlus 11 is launched in India at ₹56,999

OnePlus 11 is launched in India at ₹56,999

 OnePlus Pad Announced at Cloud 11 Event!

OnePlus Pad Announced at Cloud 11 Event!

OnePlus launches OnePlus 11R at the Cloud 11 event

OnePlus launches OnePlus 11R at the Cloud 11 event

A million Tibetan kids forced to assimilate through oppressive act: UN

A million Tibetan kids forced to assimilate through oppressive act: UN

AstraZeneca India's anti-diabetes drug gets approval from drug regulator

The company said Central Drugs Standard Control Organization's approval for its anti diabetes drug Dapagliflozin will help doctors address heart failures at an early stage

Drug firm AstraZeneca India on Tuesday said it has received approval from the country's drug regulator to market anti-diabetes medication Dapagliflozin.

The company said it has received approval from the Central Drugs Standard Control Organization (CDCSCO) for the drug indicated for diabetes patients with chronic kidney disease (CKD).

Dapagliflozin is the first and only anti-diabetic drug approved to significantly reduce the risk of sustained eGFR (estimated Glomerular Filtration Rate), cardiovascular deaths and hospitalisations due to heart failure in adults with progressive chronic kidney disease, the drug firm said.

The approval is applicable for both diabetic and non-diabetic CKD patients, it added.

CKD is one of the leading causes of hospitalisation globally and in India, representing a significant clinical and economic burden.

"The timely approval of Dapagliflozin from the CDCSCO committee with the additional indication is a huge boost for nephrologists across the country towards the management of progressive CKD," AstraZeneca India Vice President - Medical Affairs and Regulatory Anil Kukreja said in a statement.

The approval will provide the clinical community with a potential therapeutic option to arrest the progression of CKDs and address heart failures at an early stage, he added.

Also watch:Living with long Covid

Up Next

AstraZeneca India's anti-diabetes drug gets approval from drug regulator

AstraZeneca India's anti-diabetes drug gets approval from drug regulator

Shraddha's body cut into 17 pieces, moved between fridge and cabinets: Chargesheet

Shraddha's body cut into 17 pieces, moved between fridge and cabinets: Chargesheet

 Ruckus in Lok Sabha as Opposition alleges BJP MP glorified 'Sati' practice

Ruckus in Lok Sabha as Opposition alleges BJP MP glorified 'Sati' practice

 Rahul made baseless, shameless allegations against PM Modi: BJP

Rahul made baseless, shameless allegations against PM Modi: BJP

Watch: here's why Speaker Om Birla shunned BJP MP in Lok Sabha

Watch: here's why Speaker Om Birla shunned BJP MP in Lok Sabha

Delhi HC: Virginity test on women detainee or accused in custody unconstitutional

Delhi HC: Virginity test on women detainee or accused in custody unconstitutional

More videos

Prepared to respond to any aggression by China: Army Commander on LAC situation

Prepared to respond to any aggression by China: Army Commander on LAC situation

Watch: man gets 'rajma chawal' tattooed on hand, literally!

Watch: man gets 'rajma chawal' tattooed on hand, literally!

SC's assurance to Bilkis Bano: plea against remission will be heard soon

SC's assurance to Bilkis Bano: plea against remission will be heard soon

Watch: passenger gets 'windowless' seat even after booking a window seat

Watch: passenger gets 'windowless' seat even after booking a window seat

Watch: women in sarees somersault into river; video from Tamil Nadu goes viral

Watch: women in sarees somersault into river; video from Tamil Nadu goes viral

Rahul Gandhi in Lok Sabha: Senior officers say Agniveer scheme will weaken Army

Rahul Gandhi in Lok Sabha: Senior officers say Agniveer scheme will weaken Army

Adani row: Rahul Gandhi shows old pic of Modi, Gautam Adani in Lok Sabha, asks 'what's the relationship?'

Adani row: Rahul Gandhi shows old pic of Modi, Gautam Adani in Lok Sabha, asks 'what's the relationship?'

Congress infighting ahead of BMC election? Thorat quit party post amid tussle with Patole, say reports

Congress infighting ahead of BMC election? Thorat quit party post amid tussle with Patole, say reports

Protests break out as Victoria Gowri takes oath as Madras HC judge; Supreme Court junks challenge

Protests break out as Victoria Gowri takes oath as Madras HC judge; Supreme Court junks challenge

On IndiGo flight, woman falls ill, dies while being rushed to hospital after emergency landing: reports

On IndiGo flight, woman falls ill, dies while being rushed to hospital after emergency landing: reports

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.